HBV-miR-3 is closely related to HBV replication and strongly predictive of HBeAg seroconversion in PegIFN-α treated patients
Zhenyu Xu(Second Military Medical University), Guozhong Gong(Central South University), Xu Yun(Central South University), Min Zhang(Central South University), Yongfang Jiang(Central South University), Sujuan Wang(Hunan University), Zhenyu Wu(Qingdao University)
Cited by 8
Related Papers
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
|Cancer Cell|2016|1.2k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Psychological impacts and coping strategies of front-line medical staff during COVID-19 outbreak in Hunan, China
|Medical Science Monitor|2020|784
Extracellular Vesicle-Mediated Communication Within Host-Parasite Interactions
|Frontiers in Immunology|2019|175
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
|Clinical Gastroenterology and Hepatology|2019|114